NeuroAudit Petch is the first product to improve cognitive performance and support neural activation by using a low-cost, long-lasting device applying low-frequency ultrasound technology.
The product overcomes the need for the auditory system (which is often impaired in AD patients, and as such, previous brain entrainment auditory stimulations cannot be applied in such cases). NeuroAudit is a blood conduction-based stimulation.
This technology can make brain entrainment by binaural beats accessible for deaf people or patients with auditory impairment or decline.
The advantages of US-based intervention used for the NeuroAudit product:
Recent research in the therapeutic applications of ultrasound has made significant progress.
Ultrasound can be widely used in therapies, depending on the level of energy provided. In some neurological diseases, ultrasound has been used for therapeutic purposes in clinical practice and has proven effective.
The approach of ultrasound energy for therapy continues to expand; therapeutic ultrasound for the treatment of essential tremors has been approved by the United States.
Therapeutic ultrasound has also been approved in many countries for the treatment of Parkinson’s disease, neuropathic pain, and neuropsychiatric conditions, such as major depression and obsessive-compulsive disorder.
herapeutic applications of ultrasound have great potential to change treatment paradigms in various neurological diseases.